Liver disease as risk factor for cystic fibrosis‐related diabetes development
L Minicucci, R Lorini, A Giannattasio… - Acta …, 2007 - Wiley Online Library
L Minicucci, R Lorini, A Giannattasio, C Colombo, L Iapichino, MF Reali, R Padoan…
Acta Paediatrica, 2007•Wiley Online LibraryAim: To evaluate clinical and genetic factors, besides pancreatic insufficiency, associated
with increased risk of cystic fibrosis‐related diabetes. Methods: Case‐control (1: 1) study on
138 cystic fibrosis patients. Data were collected on gender, age at diagnosis, reason for
cystic fibrosis diagnosis, family history of type 1 or 2 diabetes mellitus, pre‐existing severe
liver disease, and class of cystic fibrosis transmembrane regulation mutation. Moreover,
information was obtained on lung involvement and degree of exocrine pancreatic …
with increased risk of cystic fibrosis‐related diabetes. Methods: Case‐control (1: 1) study on
138 cystic fibrosis patients. Data were collected on gender, age at diagnosis, reason for
cystic fibrosis diagnosis, family history of type 1 or 2 diabetes mellitus, pre‐existing severe
liver disease, and class of cystic fibrosis transmembrane regulation mutation. Moreover,
information was obtained on lung involvement and degree of exocrine pancreatic …
Abstract
Aim: To evaluate clinical and genetic factors, besides pancreatic insufficiency, associated with increased risk of cystic fibrosis‐related diabetes.
Methods: Case‐control (1:1) study on 138 cystic fibrosis patients. Data were collected on gender, age at diagnosis, reason for cystic fibrosis diagnosis, family history of type 1 or 2 diabetes mellitus, pre‐existing severe liver disease, and class of cystic fibrosis transmembrane regulation mutation. Moreover, information was obtained on lung involvement and degree of exocrine pancreatic insufficiency evaluated 1 year before the diagnosis of cystic fibrosis‐related diabetes in patients and age‐matched controls.
Results: Compared to controls, patients with cystic fibrosis‐related diabetes had a higher probability of having already been diagnosed with liver disease (16.7% versus 1.7%, OR = 11.6, 95% CI 1.43–93.0). Moreover, in the year before diabetes onset, cases had slightly worse pulmonary function compared to controls (FEV1= 58.4 ± 27% predicted versus 67.4 ± 21% predicted; p = 0.05). No significant effects related to the other factors considered were found.
Conclusion: Severe liver disease was found to significantly increase the risk of developing cystic fibrosis‐related diabetes. Patients with liver disease should be scheduled for earlier diabetes screening in order to identify and possibly treat glucose intolerance.
Wiley Online Library